GLAZER CAPITAL LLC 13D and 13G filings for Ibere Pharmaceuticals:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:36 pm Purchase | 2022-12-31 | 13G | Ibere Pharmaceuticals IBER | GLAZER CAPITAL LLC | 1,331,102 9.650% | 1,331,102 (New Position) | Filing |